Inventor · disambiguated record
Joseph Araujo
Also filed as: ARAUJO JOSEPH · ARAUJO JOSEPH A
11 granted patents·17 pending applications·52 citations·filing 2004–2024
88Inventor score
Top patents by PatentIndex Score
28 records- 0197US11591353B2Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disordersMINDSET PHARMA INC·Filed 2022·Granted Feb 28, 2023·9 cites·15 claims
- 0296US11597738B2Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disordersMINDSET PHARMA INC·Filed 2022·Granted Mar 7, 2023·4 cites·29 claims
- 0396US11427604B2Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disordersMINDSET PHARMA INC·Filed 2021·Granted Aug 30, 2022·4 cites·30 claims
- 0492US8578882B2System and method for cognitive enrichment of an animalARAUJO JOSEPH·Filed 2011·Granted Nov 12, 2013·29 cites·18 claims
- 0589US12378266B2Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disordersMINDSET PHARMA INC·Filed 2024·Granted Aug 5, 2025·0 cites·45 claims
- 0689US12054504B23-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disordersMINDSET PHARMA INC·Filed 2022·Granted Aug 6, 2024·1 cites·17 claims
- 0788US2025388611A1Psilocin derivatives as serotonergic psychedelic agents for the treatment of cns disordersMINDSET PHARMA INC·Filed 2024·Application pending·0 cites
- 0882US12054505B2Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disordersMINDSET PHARMA INC·Filed 2022·Granted Aug 6, 2024·0 cites·21 claims
- 0982US2023167141A1Psilocin derivatives as serotonergic psychedelic agents for the treatment of cns disordersMINDSET PHARMA INC·Filed 2023·Application pending·0 cites
- 1080US2023203070A1Psilocin derivatives as serotonergic psychedelic agents for the treatment of cns disordersMINDSET PHARMA INC·Filed 2023·Application pending·0 cites
- 1177US2024336641A13-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of cns disordersMINDSET PHARMA INC·Filed 2024·Application pending·0 cites
- 1273US8776723B2System and method for cognitive enrichment of an animalCANCOG TECHNOLOGIES INC·Filed 2013·Granted Jul 15, 2014·3 cites·20 claims
- 1373US2025034106A13-cycloamino-indole compounds as serotonergic agents useful for the treatment of disorders related theretoMINDSET PHARMA INC·Filed 2022·Application pending·0 cites
- 1472US11453689B23-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disordersMINDSET PHARMA INC·Filed 2021·Granted Sep 27, 2022·0 cites·28 claims
- 1571US2025353827A1Indoline derivatives as serotonergic agents useful for the treatment of disorders related theretoMINDSET PHARMA INC·Filed 2023·Application pending·0 cites
- 1670US8978585B2System and method for cognitive enrichment of an animalCANCOG TECHNOLOGIES INC·Filed 2014·Granted Mar 17, 2015·2 cites·20 claims
- 1770US2024376052A1N-substituted indole derivatives as serotonergic agents useful for the treatment of disorders related theretoMINDSET PHARMA INC·Filed 2022·Application pending·0 cites
- 1870US2024383850A1Indole derivatives as serotonergic agents useful for the treatment of disorders related theretoMINDSET PHARMA INC·Filed 2022·Application pending·0 cites
- 1962US2024166599A1Indole derivatives as serotonergic agents useful for the treatment of disorders related theretoMINDSET PHARMA INC·Filed 2022·Application pending·0 cites
- 2062US2024166630A1Indole derivatives as serotonergic agents useful for the treatment of disorders related theretoMINDSET PHARMA INC·Filed 2022·Application pending·0 cites
- 2156US2024342126A1Hallucinogen-fatty acid combinationMINDSET PHARMA INC·Filed 2022·Application pending·0 cites
- 2254US2024051978A13-cyclic amine-indole derivatives as serotonergic agents for the treatment of cns disordersMINDSET PHARMA INC·Filed 2021·Application pending·0 cites
- 2351US2005002863A1Method for assessing food palatability and preference in animals using a cognitive palatability assessment protocolCANCOG TECHNOLOGIES INC·Filed 2004·Application pending·0 cites
- 2448US2012077159A1System and method for cognitive assessment and training of an animalARAUJO JOSEPH·Filed 2010·Application pending·0 cites
- 2548US2009081626A1System and method for assessing cognitive function and measuring treatment efficacyMILGRAM WILLIAM·Filed 2006·Application pending·0 cites
- 2646US2007167509A1Use of phenserine and analogs to treat behavioral problems and improve trainabilityARAUJO JOSEPH·Filed 2006·Application pending·0 cites
- 2736US9481637B2Compounds for the treatment of seizures and other central nervous systems disorders and conditionsKETOGEN INC·Filed 2015·Granted Nov 1, 2016·0 cites·17 claims
- 2834US2017044095A1Compounds for the treatment of seizures and other central nervous system disorders and conditionsKETOGEN INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joseph Araujo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →